Australia markets closed

Mereo BioPharma Group plc (MREO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.2500+0.2600 (+6.52%)
At close: 04:00PM EDT
4.2510 +0.00 (+0.02%)
After hours: 07:55PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
10,000
10,000
0
49,213
0
Cost of revenue
2,921
2,574
-1,146
24,169
0
Gross profit
7,079
7,426
1,146
25,044
0
Operating expenses
Research development
16,105
17,418
29,465
31,796
22,278
Selling general and administrative
17,880
18,424
26,107
21,504
28,922
Total operating expenses
32,727
34,562
53,844
53,300
51,200
Operating income or loss
-25,648
-27,136
-52,698
-28,256
-51,200
Interest expense
2,391
2,881
4,175
5,400
8,699
Total other income/expenses net
-1,276
-2,112
13,095
52,903
-167,003
Income before tax
-26,873
-29,998
-42,938
19,220
-226,842
Income tax expense
-532
-532
-718
2,046
-3,846
Income from continuing operations
-26,341
-29,466
-42,220
17,174
-222,996
Net income
-26,341
-29,466
-42,220
17,174
-222,996
Net income available to common shareholders
-26,341
-29,466
-42,220
17,174
-222,996
Basic EPS
-0.25
-0.20
-0.36
0.13
-3.27
Diluted EPS
-0.25
-0.20
-0.36
-0.34
-3.27
Basic average shares
124,959
131,891
113,987
105,564
67,791
Diluted average shares
124,959
131,891
113,987
111,055
67,791